November 2018

Defining decision-grade real-world evidence and its role in the Canadian context:  A design sprint

As part of our mission to advance population-based research of therapeutic interventions to improve the health outcomes of Canadians, CAPT-ACTP, in conjunction with the Canadian Agency for Drugs and Technologies in Health, Health Canada, and Institute of Health Economics, hosted an October 2018 pre-Annual Conference workshop, Defining “Decision-Grade” RWE and its Role in the Canadian Context: A Design Sprint. The workshop engaged stakeholders to help identify the appropriate use of RWE to support decision-making, both from a regulatory and HTA/payer perspective. This included a shared understanding of the type of decisions RWE can most usefully support, as well as conditions upon which RWE might be considered of sufficient quality to support decision-making. To read the full report:

June 28, 2017

IHE Life Sciences Open Innovation Platform™

The Institute of Health Economics (IHE) and the Canadian Association for Population Therapeutics (CAPT) announce a partnership in support of the IHE Life Sciences Open Innovation Platform. To learn more:

News Release